3.875
price down icon3.12%   -0.125
after-market Handel nachbörslich: 3.79 -0.085 -2.19%
loading
Schlusskurs vom Vortag:
$4.00
Offen:
$4.02
24-Stunden-Volumen:
104.64K
Relative Volume:
0.22
Marktkapitalisierung:
$2.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.42M
KGV:
-0.1662
EPS:
-23.3189
Netto-Cashflow:
$-6.75M
1W Leistung:
-1.40%
1M Leistung:
-13.60%
6M Leistung:
-68.65%
1J Leistung:
-90.83%
1-Tages-Spanne:
Value
$3.82
$4.07
1-Wochen-Bereich:
Value
$3.77
$4.20
52-Wochen-Spanne:
Value
$3.25
$63.45

Silexion Therapeutics Corp Stock (SLXN) Company Profile

Name
Firmenname
Silexion Therapeutics Corp
Name
Telefon
972-8-6286005
Name
Adresse
12 ABBA HILLEL ROAD, RAMAT GAN
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
SLXN's Discussions on Twitter

Vergleichen Sie SLXN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SLXN
Silexion Therapeutics Corp
3.875 12.51M 0 -16.42M -6.75M -23.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Silexion Therapeutics Corp Aktie (SLXN) Neueste Nachrichten

pulisher
Oct 12, 2025

What MACD and RSI say about Silexion Therapeutics CorpWeekly Trade Analysis & Capital Efficiency Focused Ideas - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Long term hold vs stop loss in Silexion Therapeutics CorpMarket Performance Summary & Weekly High Conviction Ideas - newser.com

Oct 11, 2025
pulisher
Oct 11, 2025

Can Silexion Therapeutics Corp Equity Warrant stock beat analyst upgradesJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com

Oct 11, 2025
pulisher
Oct 10, 2025

Silexion Therapeutics Corp Equity Warrant stock outlook for YEAR2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Silexion Therapeutics Corp stock trendline breakdownJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What does recent volatility data suggest for Silexion Therapeutics Corp Equity WarrantWeekly Risk Report & Stock Market Timing Techniques - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What’s the recovery path for long term holders of Silexion Therapeutics Corp Equity WarrantJuly 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Silexion Therapeutics Corp Equity Warrant stock go up soon2025 Market Overview & Consistent Income Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How to integrate Silexion Therapeutics Corp Equity Warrant into portfolio analysis toolsMarket Risk Report & Reliable Price Breakout Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Silexion Therapeutics Corp stock trend forecastJuly 2025 Drop Watch & High Return Trade Opportunity Guides - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is it time to cut losses on Silexion Therapeutics CorpMarket Risk Summary & Entry Point Strategy Guides - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

What Fibonacci levels say about Silexion Therapeutics Corp Equity Warrant reboundWeekly Trade Recap & Risk Controlled Swing Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Chart based analysis of Silexion Therapeutics Corp Equity Warrant trends2025 Top Decliners & Safe Capital Growth Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What’s the recovery path for long term holders of Silexion Therapeutics Corp2025 Short Interest & Intraday High Probability Setup Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 04:43:28 - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Sentiment analysis tools applied to Silexion Therapeutics Corp Equity WarrantPortfolio Return Report & AI Powered Market Entry Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Live market analysis of Silexion Therapeutics Corp Equity WarrantPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Using Python tools to backtest Silexion Therapeutics Corp strategies2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Silexion Therapeutics Corp Equity Warrant Stock Analysis and ForecastTechnical Pattern Recognition & Boost Wealth With Growth - earlytimes.in

Oct 08, 2025
pulisher
Oct 06, 2025

How Silexion Therapeutics Corp Equity Warrant stock compares to market leadersMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Multi asset correlation models including Silexion Therapeutics Corp Equity Warrant2025 Short Interest & Daily Technical Stock Forecast Reports - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 07:04:01 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What’s next for Silexion Therapeutics Corp stock price2025 Earnings Impact & Reliable Trade Execution Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What moving averages say about Silexion Therapeutics CorpOil Prices & Precise Buy Zone Identification - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Is this a good reentry point in Silexion Therapeutics CorpForecast Cut & Stock Market Timing Techniques - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Reversal indicators forming on Silexion Therapeutics Corp stockWeekly Investment Report & Weekly Stock Performance Updates - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

Buy Rating Affirmed for Silexion Therapeutics: Promising Preclinical Data and Strategic Trial Plans Boost Investment Appeal - TipRanks

Oct 01, 2025
pulisher
Oct 01, 2025

Silexion reports pan-KRAS inhibitor shows activity across cancer types By Investing.com - Investing.com Nigeria

Oct 01, 2025
pulisher
Sep 30, 2025

Silexion Therapeutics Regains Compliance with Nasdaq - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

Silexion Therapeutics Unveils Promising SIL204 Data - TipRanks

Sep 30, 2025
pulisher
Sep 30, 2025

Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer - GlobeNewswire

Sep 30, 2025
pulisher
Sep 30, 2025

Silexion reports pan-KRAS inhibitor shows activity across cancer types - Investing.com

Sep 30, 2025
pulisher
Sep 30, 2025

Silexion Therapeutics climbs on promising cancer drug data - TradingView

Sep 30, 2025

Finanzdaten der Silexion Therapeutics Corp-Aktie (SLXN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):